MetaCap

Liquidia Statistics

NASDAQ: LQDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

54.43-2.20 (-3.88%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Liquidia by the numbers

Liquidia has a market capitalization of $4.90 billion based on 90.11M shares outstanding. With trailing EPS of $-1.05, Liquidia is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.9% above its 50-day average and 1.1% below its 200-day average.

Average daily trading volume is 3.52M shares, or about $191.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

LQDA valuation vs. peer median

LQDA compared with the median of 8 peer companies
MetricLQDAPeer medianDifference
Market cap$4.90B$4.74B+4%
Avg. volume3.52M1.44M+143%

Peer median across 8 companies: ERAS, MANE, DNTH, PTCT, COGT, BLTE, TVTX, IONS.

Valuation

Price / sales (latest FY)
30.98
EPS (TTM)
$-1.05

Price and trading

Previous close
56.63
Open
56.49
Day range
53.98 – 57.21
52-week range
22.31 – 93.61
52-week change
+86.98%
Beta
—
Volume
1.69M

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
4.90B
Forward Pe
15.12
Eps
-1.05
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
93.61
Week52 Low
22.31
Avg Volume
3.52M
Shares Outstanding
90.11M
Ma50
47.77
Ma200
55.02
Earnings Date
Nov 10, 2026
Pct From52w High
-41.85%
Pct From52w Low
143.97%

Related